Stearylsulfamide

Stearylsulfamide

SCHEMBL2367792

CCCCCCCCCCCCCCCCCC(=O)NS(=O)(=O)c1ccc(N)cc1.[AlH3]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.57
TSHR P16473 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
EPHX2 P34913 1/20 0.54
DHFR P00374 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
CA1 P00915 3/20 0.51
CA2 P00918 3/20 0.51
MAPT P10636 1/20 0.51
CA12 O43570 2/20 0.49
CA9 Q16790 2/20 0.49
RAB9A P51151 2/20 0.48
KMT2A Q03164 2/20 0.48
FBP1 P09467 1/20 0.46
LMNA P02545 2/20 0.46
MEN1 O00255 1/20 0.46
ALB P02768 1/20 0.45
CYP2C9 P11712 1/20 0.45
AKT1 P31749 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Stearylsulfamide SCHEMBL9057900 0.99 ALDH1A1 (0.56) ALDH1A1TSHRTDP1EPHX2DHFR
Stearylsulfamide SCHEMBL6650378 0.99 ALDH1A1 (0.56) ALDH1A1TSHRTDP1EPHX2DHFR
Stearylsulfamide SCHEMBL5731325 0.99 ALDH1A1 (0.58) ALDH1A1TSHRTDP1EPHX2DHFR
SCHEMBL107968 0.99 ALDH1A1 (0.58) ALDH1A1TSHRTDP1EPHX2DHFR
Stearylsulfamide SCHEMBL15335 0.99 ALDH1A1 (0.58) ALDH1A1TSHRTDP1EPHX2DHFR
Stearylsulfamide SCHEMBL17981340 0.99 ALDH1A1 (0.58) ALDH1A1TSHRTDP1EPHX2DHFR
Stearylsulfamide SCHEMBL4663113 0.97 ALDH1A1 (0.57) ALDH1A1TSHRTDP1EPHX2DHFR
Stearylsulfamide SCHEMBL5549073 0.97 ALDH1A1 (0.57) ALDH1A1TSHRTDP1EPHX2DHFR
Stearylsulfamide SCHEMBL1006541 0.97 ALDH1A1 (0.57) ALDH1A1TSHRTDP1EPHX2DHFR
Stearylsulfamide SCHEMBL322075 0.97 ALDH1A1 (0.57) ALDH1A1TSHRTDP1EPHX2DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2184109-B1 METHOD FOR PRODUCING NANOPARTICLES BY FORCED ULTRA-THIN FILM ROTARY PROCESSING M TECHNIQUE CO LTD (JP) 2017-08-23 EP disclosed
EP-2366666-A1 Process for producing a calcium hydroxide compound Kyowa Chemical Industry Co., Ltd (JP) 2011-09-21 EP disclosed
EP-2184109-A1 METHOD FOR PRODUCING NANOPARTICLES BY FORCED ULTRA-THIN FILM ROTARY PROCESSING M Technique Co., Ltd. (JP) 2010-05-12 EP disclosed
EP-1534892-A4 CHEMICALLY CROSS-LINKED CELLULOSIC FIBER AND METHOD OF MAKING SAME RAYONIER PROD & FNCL SERV CO (US) 2008-08-06 EP disclosed
EP-1394621-B1 Dry two-component type developer for electrophotography POWDERTECH CO LTD (JP) 2008-05-21 EP disclosed
EP-1667623-A4 PARTIALLY HYDRATED HEMOSTATIC AGENT Z MEDICA CORP (US) 2008-02-27 EP disclosed
EP-1667623-A2 PARTIALLY HYDRATED HEMOSTATIC AGENT Z-Medica Corporation (US) 2006-06-14 EP disclosed
EP-1534892-A1 CHEMICALLY CROSS-LINKED CELLULOSIC FIBER AND METHOD OF MAKING SAME Rayonier Products and Financial Services Company (US) 2005-06-01 EP disclosed
WO-2005027834-A2 PARTIALLY HYDRATED HEMOSTATIC AGENT Z-MEDICA CORPORATION (US) 2005-03-31 WO disclosed
WO-2003104558-A1 CHEMICALLY CROSS-LINKED CELLULOSIC FIBER AND METHOD OF MAKING SAME RAYONIER PRODUCTS AND FINANCIAL SERVICES COMPANY (US) 2003-12-18 WO disclosed
WO-2002057276-A1 PROCESS FOR PRODUCING ALUMINUM DIACETATE MONOBASIC CHATTEM CHEMICALS, INC. (US) 2002-07-25 WO disclosed
WO-2002018704-A1 ENHANCED VACUUM DEWATERING OF PULP ONDEO NALCO COMPANY (US) 2002-03-07 WO disclosed
WO-2002010133-A1 TRIDENTATE LIGANDS AND THEIR COMPLEXES WITH TRANSITION METALS POLIMERI EUROPA S.R.L. (IT) 2002-02-07 WO disclosed
EP-0996787-A1 PAPER PRODUCTS COMPRISING FILLER MATERIALS Boise Cascade Corporation (US) 2000-05-03 EP disclosed
WO-1999004092-A1 PAPER PRODUCTS COMPRISING FILLER MATERIALS BOISE CASCADE CORPORATION (US) 1999-01-28 WO disclosed